Skip to main content

Table 4 Multivariabale Analysis of Association of LGE for MACE

From: Comparison of myocardial fibrosis quantification methods by cardiovascular magnetic resonance imaging for risk stratification of patients with suspected myocarditis

Model 1

Model 2

Variables

HR (95% CI)

p-value

Variables

HR (95% CI)

p-value

 Age (years)

1.02 (1.01–1.04)

0.001

Age (years)

1.03 (1.01–1.04)

0.001

 Sex

1.73 (1.15–2.60)

0.009

Sex

1.77 (1.17–2.65)

0.007

 BMI

1.05 (1.02–1.08)

0.002

BMI

1.05 (1.02–1.08)

0.002

 LVEF

0.96 (0.95–0.97)

< 0.001

LVEF

0.96 (0.95–0.97)

< 0.001

LGE (%, FWHM)

1.04 (1.01–1.08)

0.009

LGE (%, 2-SD)

1.02 (1.00–1.04)

0.035

Model 3

Model 4

Variables

HR (95% CI)

p-value

Variables

HR (95% CI)

p-value

 Age (years)

1.03 (1.01–1.04)

0.001

Age (years)

1.02 (1.00–1.04)

0.001

 Sex

1.74 (1.16–2.62)

0.008

Sex

1.74 (1.12–2.61)

0.008

 BMI

1.05 (1.02–1.08)

0.002

BMI

1.05 (1.02–1.08)

0.003

 LVEF

0.96 (0.95–0.97)

< 0.001

LVEF

0.96 (0.95–0.97)

< 0.001

LGE (%, 3-SD)

1.02 (0.99–1.05)

0.117

LGE (%, 4-SD)

1.02 (0.98–1.05)

0.309

Model 5

Model 6

Variables

HR (95% CI)

p-value

Variables

HR (95% CI)

p-value

 Age (years)

1.02 (1.00–1.04)

0.001

Age (years)

1.02 (1.01–1.04)

0.002

 Sex

1.74 (1.16–2.61)

0.008

Sex

1.70 (1.13–2.55)

0.010

 BMI

1.05 (1.02–1.08)

0.002

BMI

1.05 (1.02–1.08)

0.002

 LVEF

0.96 (0.95–0.97)

< 0.001

LVEF

0.96 (0.95–0.97)

< 0.001

LGE (VPS)

1.07 (1.02–1.13)

0.005

LGE (VTS)

1.01 (1.00–1.03)

0.087

Model 7

Variables

HR (95% CI)

p-value

   

 Age (years)

1.02 (1.01–1.04)

0.005

   

 Sex

1.79 (1.19–2.70)

0.005

   

 BMI

1.05 (1.02–1.08)

0.001

   

 LVEF

0.96 (0.95–0.98)

< 0.001

   

LGE presence

1.82 (1.17–2.81)

0.008

   
  1. SD Standard deviation, LGE late gadolinium enhancement, LGE-VPS LGE visual presence score, LGE-VTS LGE visual transmurality score